ATTENTION AMAYA INC. SHAREHOLDERS FROM 2016 – Settlement Approval Hearing to be held
MONTRÉAL, Sept. 22, 2023 /PRNewswire/ — Law firms Faguy & Co. and Berger Montague (Canada) today announce that the Superior
Read MoreMONTRÉAL, Sept. 22, 2023 /PRNewswire/ — Law firms Faguy & Co. and Berger Montague (Canada) today announce that the Superior
Read MoreMUMBAI, India and MAHWAH, N.J., Aug. 17, 2023 /PRNewswire/ — Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated, global pharmaceutical company
Read MoreSINGAPORE, Aug. 8, 2023 /PRNewswire/ — TerraPay, a leading global payments infrastructure company, has secured an In-Principle Approval for a
Read MoreEach year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive
Read MoreSAN DIEGO, July 21, 2023 /PRNewswire/ — Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been
Read MoreSEOUL, South Korea, July 19, 2023 /PRNewswire/ — Daewoong Pharmaceutical obtained approval for a SGLT-2 inhibitor+metformin combination drug in just
Read MoreSubmits Two Design Variations to the Town Commission for Approval DUBAI, UAE and MIAMI, June 13, 2023 /PRNewswire/ — DAMAC
Read MoreMUMBAI, India, May 31, 2023 /PRNewswire/ — SGS is proud to announce that it’s Health Science laboratory based in Navi Mumbai
Read MoreGuardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for
Read MoreTAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption
Read More